NexTGen: Next Generation T Cell Therapies for Childhood Cancers CANCER GRAND CHALLENGES AWARD, IN PARTNERSHIP WITH CANCER RESEARCH UK AND THE NATIONAL CANCER INSTITUTE (2022-PRESENT) Catherine Bollard, MBChB, MD, Children’s National Medical Center; Martin Pule, MD, University College London Read More
A Proof-of-Concept Clinical Trial of an Innovative New Therapy for Glioblastoma ASPIRE Award (2022-2023) Douglas Hanahan, PhD, Ludwig Institute for Cancer Research Lausanne and the Swiss Federal Institute of Technology Lausanne (EPFL) and Andreas Hottinger, MD, PhD, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland, Switzerland Read More
CRCbioscreen Program Related Investment (2021) Gerrit Meijer, MD, PhD, the Netherlands Cancer Institute Read More
Targeting Insulin to Improve Endometrial Cancer In Partnership with The American Association for Cancer Research (2020-2024) Marcus D. Goncalves, MD, PhD, Weill Cornell Medicine Read More
Overcoming BRAF/MEK Inhibition Resistance in Anaplastic Thyroid Carcinoma ASPIRE Award (2020-2024) Jennifer Wang, MD (Principal); Mark Zafereo, MD; and Wenyi Wang, PhD, The University of Texas MD Anderson Cancer Center Read More
A Liquid Biopsy Test for the Early Detection of High-Risk Colorectal Adenomas ASPIRE Award, (2020-2022) Dan Landau, MD, PhD, Weill Cornell Medicine (Principal) and Claus Andersen, PhD, Aarhus University Read More
